# Citrate Anticoagulation for Postdilution Hemofiltration

> **NCT03969966** · — · UNKNOWN · sponsor: **Heinrich-Heine University, Duesseldorf** · enrollment: 100 (estimated)

## Conditions studied

- Acute Kidney Injury
- Critical Illness

## Interventions

- **OTHER:** renal replacement therapy as clinically indicated

## Key facts

- **NCT ID:** NCT03969966
- **Lead sponsor:** Heinrich-Heine University, Duesseldorf
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-14
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03969966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03969966, "Citrate Anticoagulation for Postdilution Hemofiltration". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03969966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*